资讯

Three popular over-the-counter pain medications have been recalled by Glenmark Pharmaceuticals Inc. USA due to manufacturing issues, according to the Food and Drug Administration.
The Healthy @Reader's Digest on MSN7 小时
3 Popular Pain Relievers Have Been Recalled Nationwide
You might have a preferred over-the-counter medication that just seems to metabolize effectively in your body to bring down ...
You may assume that scurvy is a disease that died out in the Victorian times. But now, as cases rise, a leading pharmacist has warned that it's not just malnutrition that causes the disease.
If you take more than the recommended dosage or more than one type of NSAID at once — for example, combining Motrin and Aleve ...
Several studies have been done on the myriad list of side effects that come from popular weight loss drugs. A new study conducted by researchers from t… ...
Rybelsus (semaglutide) and Ozempic (semaglutide) are prescription drugs used to treat type 2 diabetes. Rybelsus comes as an oral tablet, while Ozempic comes as an injectable liquid solution.
Trump said he wants to bring more drug manufacturing to the U.S. At a political fundraising dinner on Tuesday night, President Donald Trump said he plans to announce tariffs on pharmaceuticals soon.
And even as drug shortages may worsen and prices increase in the nearer term, experts are skeptical that tariffs would achieve their main stated goal of bringing drug manufacturing back to the US.
DUBUQUE, Iowa (KCRG) - A Dubuque man has been sentenced to 12 years in prison for distributing meth and fentanyl pills. 45-year-old Dubuque resident Ian Bonnette pleaded guilty to conspiracy to ...
This little pill — taken by adults and children alike — might just be a prescription for heart disease. Speaking to The Post, the veteran heart doctor tackled a drug that is commonly ...
Dr. Evan Levine tackles a drug that is often prescribed to help children perform better -- a phenomenon he calls "borderline child abuse." ...
The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors, representing an innovative approach to metabolic health. Prices range from Rs3,500 to Rs4,375 per vial.